down arrow

Gland Pharma

41
Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
1,401.40
8.15 (0.58%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
Operating Income
5,664.00
3,624.00
4,400.00
3,462.00
2,633.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
5,664.00
3,624.00
4,400.00
3,462.00
2,633.00
Expenditure (Ex Depriciation)
Stock Adjustments
127.00
-46.00
36.00
-273.00
-6.00
Raw Materials Consumed
2,045.00
1,732.00
2,072.00
1,765.00
1,108.00
Power & Fuel Cost
229.00
124.00
95.00
74.00
78.00
Employee Cost
1,256.00
403.00
338.00
311.00
277.00
Operating Expenses
295.00
153.00
137.00
130.00
102.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
37.00
27.00
40.00
36.00
17.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
89.00
44.00
32.00
23.00
18.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
4,331.00
2,599.00
2,890.00
2,160.00
1,677.00
Operating Profit (PBDIT) excl Other Income
1,333.00
1,024.00
1,510.00
1,302.00
955.00
Other Income
170.00
240.00
223.00
134.00
139.00
Operating Profit (PBDIT)
1,503.00
1,265.00
1,734.00
1,437.00
1,094.00
Interest
26.00
7.00
5.00
3.00
7.00
Profit before Depriciation and Tax
1,477.00
1,257.00
1,728.00
1,433.00
1,087.00
Depreciation
344.00
146.00
110.00
98.00
94.00
Profit Before Taxation & Exceptional Items
1,132.00
1,111.00
1,618.00
1,334.00
992.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,132.00
1,054.00
1,618.00
1,334.00
992.00
Provision for Tax
360.00
273.00
406.00
337.00
220.00
Profit After Tax
772.00
781.00
1,211.00
996.00
772.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
6,015.00
5,234.00
4,022.00
3,025.00
2,252.00
Profit Available for appropriations
6,787.00
6,015.00
5,234.00
4,022.00
3,025.00
Appropriations
6,787.00
6,015.00
5,234.00
4,022.00
3,025.00
Equity Dividend (%)
2,000.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
46.90
47.44
73.81
63.07
49.88
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 56.29% vs -17.64% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 30.09% vs -32.14% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 251.82% vs 42.06% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is -1.10% vs -35.54% in Mar 2023

Compare Profit and Loss Results of Gland Pharma
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
5,664.00
10,334.00
-4,670.00
-45.19%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
5,664.00
10,334.00
-4,670.00
-45.19%
Expenditure (Ex Depriciation)
Stock Adjustments
127.00
-94.00
221.00
235.11%
Raw Materials Consumed
2,045.00
3,263.00
-1,218.00
-37.33%
Power & Fuel Cost
229.00
129.00
100.00
77.52%
Employee Cost
1,256.00
2,274.00
-1,018.00
-44.77%
Operating Expenses
295.00
210.00
85.00
40.48%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
37.00
928.00
-891.00
-96.01%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
89.00
134.00
-45.00
-33.58%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
4,331.00
7,798.00
-3,467.00
-44.46%
Operating Profit (PBDIT) excl Other Income
1,333.00
2,536.00
-1,203.00
-47.44%
Other Income
170.00
280.00
-110.00
-39.29%
Operating Profit (PBDIT)
1,503.00
2,817.00
-1,314.00
-46.65%
Interest
26.00
35.00
-9.00
-25.71%
Profit before Depriciation and Tax
1,477.00
2,782.00
-1,305.00
-46.91%
Depreciation
344.00
398.00
-54.00
-13.57%
Profit Before Taxation & Exceptional Items
1,132.00
2,384.00
-1,252.00
-52.52%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,132.00
2,399.00
-1,267.00
-52.81%
Provision for Tax
360.00
457.00
-97.00
-21.23%
Profit After Tax
772.00
1,926.00
-1,154.00
-59.92%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
6,015.00
8,012.00
-1,997.00
-24.93%
Profit Available for appropriations
6,787.00
9,925.00
-3,138.00
-31.62%
Appropriations
6,787.00
9,925.00
-3,138.00
-31.62%
Equity Dividend (%)
2000%
0%
2,000.00
Earnings Per Share
46.9
47.75
-0.85
-1.78%
Profit And Loss - Net Sales
Net Sales 5,664.72 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 56.29% vs -17.64% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,333.07 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 30.09% vs -32.14% in Mar 2023

Profit And Loss - Interest
Interest 26.20 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 251.82% vs 42.06% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 772.46 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -1.10% vs -35.54% in Mar 2023